Erasca market cap ERAS
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Nov 2, 2026
- $4.9B
- Highest close in our data
- $6.7B
- Apr 2026
Erasca is worth $4.9B at the close on Nov 2, 2026, at $14.05 a share.
That is up 663% over the last year and up 105% over five years.
Its highest close in our data was $6.7B in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $4.9B | $1B | $6.7B | +398% |
| 2025 | $987.3M | $328.6M | $1B | +37% |
| 2024 | $718.1M | $255.3M | $887.1M | +123% |
| 2023 | $321.8M | $252.3M | $532.3M | −39% |
| 2022 | $527.4M | $501.7M | $1.6B | −72% |
| 2021 | $1.9B | $1.7B | $2.9B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Erasca's size, closest first, today.
| Company | Market cap |
|---|---|
| ERASErasca | $4.9B |
| INDVIndivior Pharmaceuticals | $4.3B |
| LGNDLigand Pharmaceuticals | $6.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| LQDALiquidia | $3.7B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| OGNOrganon | $3.6B |
| KNSAKiniksa Pharmaceuticals International | $7.1B |
| ALKSAlkermes plc. | $7.5B |
| NRIXNurix Therapeutics | $2.8B |
| CORTCorcept Therapeutics | $8.7B |
| Peer median | $5.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Erasca
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.